🚀 For Investors & Partners

VedaRx Innovation Hub

Explore our medical device pipeline, upcoming innovations, market opportunities, and investor resources. India's next healthcare technology leader is building the future — be part of it.

📊 View Pipeline 💼 Investor Centre 📝 Express Interest
🏢 Mumbai HQ  |  CIN: U87200MH2024PTC416934  |  CDSCO Registered  |  ISO Compliant
📈 Market Opportunity

India MedTech: The $50B Opportunity

India's medical device market is one of the fastest growing in the world, driven by rising chronic disease burden, government support, and rapid digital health adoption.

$15.4B
Current Market Size (2025)
~$50B
Projected by 2030
~22%
CAGR 2025–2030
1.4B+
Population Addressable
740M+
Digital Health Users
77%
Import Dependency (Opportunity)
In Development

Medical Device Innovation Pipeline

From concept to commercial launch — our R&D pipeline spans multiple therapeutic areas with a focus on AI-augmented, affordable devices for the Indian and global market.

🤖
Clinical Trials

AI-Powered Fundus Screening Device

Non-mydriatic fundus camera with on-device AI for automatic diabetic retinopathy grading. Designed for primary care settings and rural health camps.

📅 Commercial launch: Q4 2026 🎯 Target: Primary care, rural India
Development progress65%
💓
Prototype

Wearable Continuous BP Monitor

Cuffless, optical PPG-based wearable for continuous blood pressure monitoring. Aimed at hypertension management and post-cardiac event monitoring.

📅 Commercial launch: Q2 2027 🎯 Cardiology + Remote monitoring
Development progress40%
🧬
CDSCO Approval

Point-of-Care NGS Rapid Diagnostic System

Portable NGS platform for rapid pathogen identification and AMR profiling at the point-of-care, reducing turnaround from days to hours.

📅 Commercial launch: Q1 2027 🎯 ICU, Infection disease, AMR
Development progress80%
🛡️
Market Ready

CliniSense — IoT Vital Signs Monitor

Multi-parameter IoT patient monitor (SpO2, ECG, temp, NIBP) with cloud dashboard integration. CDSCO approved. Now available for hospitals pan-India.

📅 Available: Now 🎯 Hospitals, ICU, Home care
Development progress100%
🧠
Concept Phase

AI Stroke Detection EEG Headset

Lightweight, wireless EEG device with AI algorithm for early stroke signature detection in emergency settings and teleneurology applications.

📅 Commercial launch: Q4 2028 🎯 Emergency medicine, Neurology
Development progress15%
🌡️
Prototype

Smart Insulin Delivery Patch

Skin-wearable micro-needle insulin delivery patch with smartphone-connected continuous glucose feedback for closed-loop insulin delivery in Type 1 diabetes.

📅 Commercial launch: Q3 2028 🎯 Endocrinology, T1DM, Paediatrics
Development progress30%
Roadmap 2026–2028

Innovation Milestones

Q2 2026
AI Fundus Device — Clinical Trial Completion
Complete Phase III validation studies across 6 centres in India
Q3 2026
POC NGS System — CDSCO Approval
Receive Class C device approval with pilot deployment at 10 hospitals
Q4 2026
AI Fundus Device — Commercial Launch
Market launch targeting 2,000 primary health centres in Maharashtra
Q2 2027
Wearable BP Monitor — Market Entry
Pan-India launch through hospital supply chain and D2C channels
2028
AI Stroke EEG + Smart Insulin Patch — Development Completion
Prototype completion and initiation of regulatory submissions
Investor Resources

Download Investor Materials

Access our latest corporate overview, device pipeline briefs, market reports, and partnership opportunities.

📊
Corporate Overview & Company Profile
VedaRx story, services, traction, and vision
Request
🩺
Medical Device Pipeline Report 2026
Detailed pipeline, timelines, and investment needed
Request
📈
India MedTech Market Analysis 2026
Market sizing, competitive landscape, and opportunity
Request
🤝
Strategic Partnership Framework
Distribution, co-development, and licensing models
Request
🏆
Clinical Trial Services Capability Deck
CRO/SMO capabilities, site network, and track record
Request
💼 Investment

Partnership & Investment Opportunities

VedaRx offers multiple entry points for investors, strategic partners, distributors, and corporate clients looking to participate in India's medtech revolution.

💰

Equity Investment

Participate in our Series A fundraise to fuel device manufacturing scale-up, clinical trial expansion, and pan-India commercial deployment. Expected return: 5–8x in 5 years.

🤝

Strategic Co-Development

Partner with VedaRx on joint device R&D, contribute IP, technical expertise, or manufacturing capability. Revenue sharing and co-ownership models available.

🚚

Distribution Partnership

Become an authorized distributor of VedaRx devices in your state or region. Exclusive territory rights available for qualified healthcare distribution partners.

🏥

Hospital / Institution Clients

Enterprise licensing of CliniFlow platform, bulk device procurement, and dedicated clinical research collaboration for hospital systems and medical colleges.

📝 Get Started

Express Your Interest

Fill out this short form and our business development team will contact you within 48 hours with a customised information pack.